In human vitiligo, cutaneous depigmentation involves cytotoxic activity of autoreactive T cells. It was 
Introduction
Vitiligo is characterized by progressive loss of skin pigmentation. This autoimmune disorder strikes approximately 0.5-1% of the world population (Taieb et al., 2007) . Depigmentation involves progressive loss of melanocytes from the basal layer of the epidermis (Le Poole et al., 1993) . Moreover, depigmentation is associated with inflammatory infiltrates of T cells and macrophages (Van den Wijngaard et al., 2000) . In progressive disease, the CD4 ⁄ CD8 ratio is decreased among skin-infiltrating T cells and CD8 + T cells isolated from vitiligo skin are cytotoxic to melanocytes (Wankowicz-Kalinska et al., 2003) . An increased number of Melanoma Antigen Recognized by T cells (MART-1) reactive T cells has been reported among peripheral T cells from patients with active disease, and MART-1 reactivity as well as gp100 reactivity have likewise been demonstrated among skininfiltrating T cells (Ogg et al., 1998; Oyarbide-Valencia et al., 2006; Wankowicz-Kalinska et al., 2003) .
MART-1 and gp100 were first identified as target antigens for T cells infiltrating melanoma tumors. This raised the intriguing question, why the autoimmune response to melanocytes effectively eliminates melanocytes from vitiligo skin whereas T cells infiltrating melanomas fail to clear the tumor. In the past we have proposed that a failure to suppress an ongoing immune response to self antigens may contribute to progressive depigmentation of the skin in vitiligo patients (Das et al., 2001) . Regulatory T cells are known to inhibit autoreactivity, explaining why autoreactive T cells are present in the circulation in the absence of autoimmune symptoms (Baecher-Allen and Hafler, 2006) . While the mechanism of action for Treg is still not fully understood, TGF-b and IL-10 contribute to Treg mediated immunosuppression. TGF-b is important for imposing a regulatory phenotype to the Treg subset and regulatory activity is dependent on cell-cell contact (Bala and Moudgil, 2006; Joetham et al., 2007; Zhu and Paul, 2008) . Markers expressed by Treg include FoxP3, GITR, CTLA-4 and CD25, yet only FoxP3 expression is relatively unique to regulatory T cells (De Boer et al., 2007) . This transcription factor affects the expression of many genes (Zheng and Rudensky, 2007) , and mutations in FoxP3 can cause severe autoimmune disease as in IPEX (human) and scurfy mice, supporting the importance of Treg to keep autoreactive T cells in check (Lahl et al., 2007 ). An abundance of Treg in tumor tissues is thought to be the root cause of failing attempts to boost anti-tumor immunity by powerful vaccines, and inclusion of FoxP3 as a target antigen in vaccines was shown to boost anti-tumor immunity (Loddenkemper et al., 2009; Nair et al., 2007) . This holds true in particular for melanoma, where self antigens MART-1 and gp100 are among the most immunogenic antigens targeted by the host anti-tumor response (Chakraborty et al., 2004) . Among circulating Treg, a large proportion is set to home to the skin (Hirahara et al., 2006) . Chemokine CCL1 and its receptor CCR8 are involved in the chemoattractive process that guides Treg to the skin, as are the combinations of CCL5 and CCR5 and of CCL22, CCL17 and CCR4 (Colantonio et al., 2002; Hirahara et al., 2006) . The cutaneous lymphocyte antigen (CLA) is a ligand for selectinlike molecules PCAM and ECAM on the endothelial cell surface in a process that determines skin homing of lymphocytes including Treg (Iellem et al., 2003) . We have previously reported that CLA is abundantly expressed by CD4 + and CD8 + T cells that infiltrate vitiligo skin (Van den Wijngaard et al., 2000) .
Recent advances made in understanding the contribution of regulatory T cells to keep autoimmune responses in check have provided incentive for the current study on the abundance, location and activity of regulatory T cells in vitiligo. Immuno double staining was performed to detect and quantify FoxP3 expressing T cells infiltrating non-lesional, perilesional and lesional vitiligo skin, comparing Treg abundance in diseased and normal control skin. Although vitiligo manifests itself in the skin, an important part of the etiology is defined elsewhere. Failure to clonally delete T cells with high affinity, melanocyte reactive TCR for example, occurs in the thymus . Therefore, besides including patient skin samples, the current studies describe skin homing and T cells migrating to skin from the circulation. In lupus eythematosus for example, an intrinsic migratory defect may account for reduced Treg in affected tissues (Lee et al., 2008 
Results

Paucity of Treg in vitiligo skin tissue samples
Frozen skin sections from 3 mm biopsies double stained for expression of CD3 and FoxP3 were used to evaluate the abundance of Treg in human skin. Treg frequency among infiltrating pan T cells was compared for normal neonatal (n = 5) and adult skin (n = 5), lentigo maligna samples (n = 4) and non-lesional, perilesional, and lesional vitiligo skin (n ‡ 7 each). Cells were quantified in multiple sections of each sample and the Treg fraction among T cells was determined as shown in Figure 1 . A significantly reduced percentage of Treg among infiltrating T cells was noted for non-lesional (2.6 ± 3.5%) as well as perilesional (2.0 ± 1.6%) and lesional vitiligo skin (7.3 ± 13.9%) as compared to normal skin from unaffected adults with fluctuating Treg content (46.2 ± 37.8%). The abundance of Treg was not significantly altered when comparing adult to neonatal skin (42.6 ± 16.2%), or adult skin to lentigo maligna samples (57.8 ± 42.4%). In the latter, the overall number of infiltrating T cells was elevated, with similar frequencies of Treg among them. In vitiligo perilesional skin, where the absolute numbers of T cells are increased relative to normal control skin, this increase was not accompanied by a relative increase in Treg.
Circulating Treg quantified
The data presented in Figure 1 initially suggested that Treg may be sparse in vitiligo patients per se, as a reduced frequency was observed not only in involved, but also in unaffected skin. Thus circulating Treg were stained using a combination of surface markers including CD4, and CD25 expression as well as reduced expression of CD127, followed by FoxP3 immunostaining of permeabilized lymphocytes. The data are illustrated in Figure 2 (A), and quantified in Figure 2( Lentigo (4) Neonate (5) Adult (5) Non-lesional (8)
Peri-lesional (7) Lesional ( The percent Treg among T cells was calculated for 4-8 samples in each group, looking for significant differences to the % Treg found in adult normal skin by Student's T test, with **P < 0.01, and *P < 0.05.
Differential expression of skin homing receptors
An apparent discrepancy between abundant Treg present in the circulation of vitiligo patients, whereas such Treg are not found in the skin may be explained by a failure of Treg to migrate into the skin. To differentiate circulating Treg destined to home to the skin, FACS staining performed included analysis of CLA expression, as well as expression of CCR4, CCR5 and CCR8 among Treg from control and patient samples. Since the % Treg observed in skin was reduced regardless of depigmentation status as shown in Figure 1 , no differentiation was made between patients with active or stationary disease for these experiments. The data represented in Figure 4 , show gating strategies (A) and summarized data (B) representing expression of CCR4, CCR5, CCR8 and CLA among Treg in vitiligo patients and controls (n ‡ 7 as shown). The data demonstrate that expression of receptors previously shown to dictate homing of T cells and specifically Treg to the skin compartment is similar among the patient and control populations, although a slight trend towards increased expression of CCR4 (at 51% of control versus 41% of vitiligo Treg) as well as CCR5 (at 15% of control versus 10% of vitiligo Treg) is present. CLA expression in control and vitiligo skin in double stainings with FoxP3 revealed that cells in vitiligo skin expressing the skin homing receptor are not Treg (not shown). 
Absence of Treg in vitiligo skin
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Differential chemoattraction of Treg populations to the skin in vitiligo
To further investigate whether reduced expression of chemoattractants may have contributed to the paucity of Treg within vitiligo patient skin, experiments were focused on expression of CCL1, CCL17 and CCL22. Expression was assessed by immunostaining for these chemokines in n ‡ 7 samples of control and vitiligo skin each. CCL1 (average 1120 expressing cells ⁄ mm 2 for all samples) and CCL17 (average 550 expressing cells ⁄ mm 2 for all samples) expression were similar among immunostained sections of control and vitiligo skin (not shown), yet CCL22 expression (in expressing cells ⁄ mm 2 ) was markedly reduced by 43% among vitiligo samples compared to control skin as exemplified in Figure 5 (A, B) and quantified in (C), suggesting that Tregs may not be as enticed to extravasate and migrate towards the skin by the chemokine in vitiligo. Vitiligo and control Treg responded equally well to chemoattractant CCL22 in migration assays, as shown in Figure 5 (D), suggesting a reduction in the number of CCL22 expressing cells within patient skin is primarily responsible for impaired immigration.
Discussion
The presence of regulatory T cells serves to prevent autoimmune reactivity by T cells that express receptors reactive with self-peptides (Danese and Rutella, 2007) . Since many anti-tumor vaccines are aimed at boosting reactivity to self-peptides, the regulatory subpopulation of T cells can interfere with anti-tumor efficacy. In fact, depletion of regulatory T cells has been suggested as a means to enhance anti-tumor responses while increasing risk for the development of autoimmunity as demonstrated in human patients and associated mouse models (Dannull et al., 2005; Jacob et al., 2009; Mahnke et al., 2007) . In mice vaccinated against melanoma differentiation antigens including gp100 and MART-1, it appears that Treg depletion is accompanied by depigmentation of the pelage (Sutmuller et al., 2001) . These data support the concept that in the absence of Treg, T cells reactive to melanocyte differentiation antigens demonstrate an unbridled response to melanocytes.
Research from several groups supports the involvement of autoreactive, cytotoxic T cells in progressive depigmentation of human skin, and cytotoxic T lymphocyte (CTL) activity can induce depigmentation in a mouse model of human vitiligo (Das et al., 2001; Denman et al., 2008) . The fact that melanocyte reactive CD8 + T cells are also found in control individuals without vitiligo suggests that autoimmune reactivity is kept in check in the periphery, and that this checkpoint is defective in vitiligo (Visseren et al., 1995) . The current data support this hypothesis.
The number of transcription factor FoxP3 expressing T cells was significantly reduced in the skin of vitiligo patients. Such reduction was observed not only in perilesional skin (the site where regulatory activity is needed to suppress the activity of helper and cytotoxic T cells that are actively contributing to depigmentation) but also in non-lesional and in lesional skin. By contrast, the percentage of Treg in lentigo maligna lesions was comparable to control skin. In both lentigo-affected and adult control samples, the percentage of infiltrating Treg was highly variable as can be expected in response to diverse environmental conditions. Depending on the purpose of the study, publications frequently report on the percentage of Treg among CD4 cells instead. Also, different antibodies with reduced sensitivity to FoxP3 may be used. In studies where authors are seeking to identify an increase in Treg abundance, the use of lower avidity antibodies can be fortuitous for that purpose. To allow for a direct data comparison, we have chosen to use the same antibodies in separate studies (see Le Poole et al., 2008) . Markedly different percentages of Treg among skin T cells in vitiligo patient and control skin were further supported in a pilot experiment to compare the abundance of Treg among lymphocytes emigrating from skin tissue samples on fibronectin over the course of 2 weeks, at 15.9% from vitiligo and 83.3% from control skin. As CD8 + T cells abundantly infiltrate lentigo maligna samples yet the proportion of Treg is maintained, the marked reduction in the proportion of Treg within vitiligo skin cannot simply be explained by a relative increase in the influx of effector T cells (Le Poole et al., 2002) . We have previously reported an influx of (IFN-c producing) T cells in lentigo maligna, and the absolute number of infiltrating effector cells is generally greater in lentigo maligna than in vitiligo (Le Poole et al., 2002) . Such a difference in the number of effector cells between lentigo maligna and vitiligo is perhaps not surprising, since the concentration of target cells for the immune response is greater in lentigo maligna than in vitiligo. In a preliminary experiment (unpublished), quantitative PCR data from perilesional skin of a progressive vitiligo patient compared to normal control skin suggest that reduced infiltration by Treg is accompanied by a 42-fold increase in IFN-c transcript abundance and a 10% decrease in IL-10 transcript abundance (b-actin transcript abundance serving as the internal reference), favoring a proinflammatory versus an immunosuppressive environment.
Since an influx of effector T cells in vitiligo is not accompanied by an influx of Treg and in fact, resident Treg are reduced in non-lesional (and lesional) vitiligo skin, these data suggest that an ongoing immune response to self antigens as observed in generalized vitiligo is not kept in check by the appropriate immune regulatory mechanisms within the skin. In vitiligo patients, ongoing immunity is specifically directed against melanocytes and targets melanosomal proteins, and increased numbers of melanocytereactive T cells are observed in the circulation. In vitiligo patients, T cells with high affinity for melanosomal antigens escape clonal deletion in primary lymphoid organs, and T cell tuning may allow this process to go forward (Van den . It follows that in the absence of a regulatory component, these patients will preferentially develop vitiligo, whereas we and others have reported cases of coinciding vitiligo and psoriasis as well (Al-Mutairi and Al-Doukhi, 2009; Hernandez et al., 2008) . In bona fide cases of psoriasis however, non-functional Treg present in equal numbers are more commonly held responsible for progressive disease (Goodman et al., 2009) . Another inflammatory skin condition involving a T cell component where we have studied the involvement of Treg is condylomata. Here we found the Treg compartment to be significantly more abundant than in control skin, which likely contributes to the lack of CTL efficacy in eliminating existing warts from the skin (Le .
The abundance of circulating Treg was similar among vitiligo patient samples compared to controls. Indeed, if the percentage of Treg among circulating T cells were reduced, one would expect vitiligo patients to suffer from generalized autoimmunity. Whereas vitiligo patients do display an increased incidence of several autoimmune diseases, most notably of Hashimoto's thy- (C) The data reveal a significantly reduced abundance of CCL22 expressing non-lesional and intra-lesional vitiligo skin (P < 0.05). Treg migration in response to CCL22 was also determined in control and vitiligo samples (D). Treg abundance among migrated CD4 + lymphocytes was measured in the absence (spontaneous migration) or presence of CCR4 ligand CCL22. Treg migration data were summarized showing no difference in the % Treg responding to CCL22 among control and vitiligo CD4 + lymphocytes.
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This article is a US Government work and is in the public domain in the USAroiditis (Kakourou et al., 2005) , the majority of patients are only affected by progressive depigmentation of the skin. Thus it was not surprising to find that vitiligo patients carry similar numbers of Treg in the circulation. Treg circulating in abundance among vitiligo patients compared to control individuals signal an attempt of the immune system to compensate for an effector response to self antigens, accompanying an increased number of effector T cells previously noted for vitiligo patients with active disease (Ogg et al., 1998) . Clearly however, these circulating Treg are incapable of keeping the autoimmune response to melanocytes in check, suggesting a possible defect in regulatory function. This prompted our studies to delineate the ability of circulating Treg to control T cell proliferation, comparing Treg isolated from patients with those isolated from control individuals. Our data however demonstrate, that circulating Treg from vitiligo patients-regardless of the activity of their disease-are functional and capable of inhibiting helper T cell proliferation. Observing a near complete absence of Treg in the skin, whereas functional Treg were abundant in the circulation of vitiligo patients prompted us to investigate the expression of markers associated with Treg skin homing. Cutaneous lymphocyte antigen (CLA), CCR4 and CCR8 have been implicated in this process, and expression of these markers was compared among control and patient samples. In melanoma, we have recently observed significant overexpression of CCR4 and CCR8 measured as both the number of expressing cells and the abundance ⁄ cell among circulating Treg, accompanied by marked expression of the ligands within the tumor environment [ (Klarquist et al., 2009 (abstract) ]. By contrast, the percentage and abundance of expression of CLA, CCR4, CCR5 and CCR8 was comparable among vitiligo patient and control samples although a trend towards decreased expression of CCR4 and CCR5 were observed among vitiligo patient samples. Although outside the scope of the current Treg study, another notable difference was significantly increased expression of CCR8 among non-Treg lymphocytes (both CD4 + and CD8 + ) at P < 0.01 for each subset, implicating CCR8 in infiltration of proinflammatory T cells into vitiligo skin (not shown).
Markedly differential engagement of chemokine CCL22 was observed, strongly suggesting that impaired skin homing contributes to reduced regulatory activity in the skin environment of vitiligo patients. As patient Treg did not display an intrinsic disability to respond to CCL22 with increased migration, the actual reduction in the number of chemokine expressing cells within patient skin is thought to be primarily responsible for impaired immigration. Remaining expression of CCL22 even among patient skin samples may explain the occasional detection of residual Treg in vitiligo skin. A difference in migration could not be assigned to a lack of CCL1 or CCL17 expression in vitiligo, as patient skin expressed similar levels of the chemokines by immunohistochemistry. It should be noted that the proportion of Treg will be further influenced within the skin environment itself, possibly by differential abundance of IL-6 that can stimulate a pro-inflammatory, Th17-dominated environment as demonstrated for psoriasic lesions (Goodman et al., 2009) .
Taken together, an inadequate number of Treg will not be able to suppress an ongoing cytotoxic response in vitiligo skin. Indeed, our data support that a reduced proportion of Treg is retained in the skin of vitiligo patients, and such reduction is accompanied by reduced expression of CCL22. We have previously reported an abundance of CLA expressing T cells in perilesional skin of vitiligo patients with active disease (Van den Wijngaard et al., 2000) , and immuno double staining of skin sections with antibodies to FoxP3 and CLA further confirmed that CLA expression in vitiligo skin was not accompanied by expression of regulatory T cell markers (not shown). Taken together, the data can help to explain continued cytotoxic T cell activity contributing to progressive depigmentation. This mechanism may be unique to vitiligo, and differs from other autoimmune disease of the skin, where Treg are abundant in the skin and blood, but appear to display deficient regulatory activity (Sugiyama et al., 2005) . The data support a mechanism of reduced homing to the destination site for Treg, allowing an active immune response to melanocytes to proceed despite an abundance of functional Treg circulating in vitiligo patients. The importance of conditions encountered by Treg during priming in peripheral lymph nodes for organ-selective homing (Siewert et al., 2007) , as well as reports of temporal changes in Treg function over time (Smyk-Pearson et al., 2008) suggests that opportunities may exist to manipulate the skin-seeking behavior of Treg in vitiligo.
Materials and methods
Patient population
For studies involving blood derived lymphocytes, a total of 30 ml of blood was drawn from patients diagnosed with generalized vitiligo, with either stationary or progressive disease. All patients provided informed consent under IRB approval from Loyola University Chicago. PBMC were isolated by Ficoll gradient, frozen in presence of 10% DMSO in fetal bovine serum (FBS) and stored in liquid nitrogen until use. Control blood was purchased from Life Source in Chicago, IL, USA.
Four mm skin biopsies from vitiligo patients included in this study were obtained under local anesthesia from consenting adults for studies approved by the IRB at Loyola University Chicago. Control skin or tumor samples were obtained as otherwise discarded tissue obtained either during circumcision, abdominoplasty, mamma reduction or during tumor resection, respectively through IRB approved protocols at Loyola University in conjunction with the Departments of Surgery at the University of Chicago (IL) and the University of Cincinnati (OH).
All patient information available and relevant to the study is summarized in Table 1 .
Monoclonal antibodies
Monoclonal antibodies used for immunostaining of skin specimen, FACS analysis and sorting of peripheral blood samples include antibodies to human antigens CD3 (clone F7.2.38, BD Biosciences, San Jose, CA, USA); unlabeled or 
Immunohistology
Single immunostaining procedures were performed essentially as described (Le Poole et al., 2002) . Briefly, 8 lm frozen and acetone fixed tissue sections were exposed to an antibody of interest in empirically optimized concentrations, followed by incubations with biotinylated rabbit anti-mouse antiserum 1:200 (DakoCytomation, Glostrup, Denmark) and peroxidase-labeled streptavidin 1:300 (DakoCytomation). Color was developed in presence of 250 lg ⁄ ml AEC and 0.03% H 2 O 2 and sections were counterstained in Harris modified hematoxilin (Sigma Aldrich, St. Louis, MO) before coverslipping.
Immuno double stainings were similarly performed on frozen sections, essentially as described (Le Poole et al., 2002) . Briefly, fixed sections were exposed to a combination of two primary antibodies of different isotypes. Washed sections were then exposed to a combination of isotype-specific secondary antibodies labeled either with peroxidase or alkaline phosphatase (Southern Biotechnologies, Birmingham, AL, USA). Fast Blue BB (Sigma Aldrich) substrate was used to develop blue color by alkaline phosphatase followed by AEC substrate (Sigma Aldrich) to develop red color in presence of peroxidase.
FACS analysis
For Treg quantification and analysis of homing markers, between 2 and 5 million frozen PBMC were thawed and incubated in the presence of primary antibodies labeled as follows: PBMCs were first negatively sorted for T cells on an EasySep magnet using a T cell enrichment antibody cocktail (StemCell Technologies, Vancouver, BC, Canada). Then, antibodies to were plated alone or combined in equal cell numbers per well. Cells were co-incubated for 72 h prior to addition of 30 Gy irradiated mature dendritic cells, generated from adherent monocytes cultured in AIMV (Invitrogen) in presence of 100 IU ⁄ ml of IL-4 (R&D Systems) and 400 IU ⁄ ml of GM-CSF (Berlex Laboratories, Richmond, CA, USA) for 7 days, adding 1000 IU ⁄ ml of IFN-c (R&D systems) for the last 48 h of culture to achieve DC maturation (Pan et al., 2004) . At the same time, 2 lCi of 3H-thymidine (25 Ci ⁄ mmol specific activity; Amersham Biosciences, Piscataway, NJ, USA) was added per well and cells were co-incubated for an additional 24-h period. In control wells, CD4 + ⁄ CD25 
Migration assays
Migration assays were performed essentially as described (McFadden et al., 2007) and modified to measure the response of Treg to chemoattractant CCL22. Briefly, 10 6 control or vitiligo PBMC (n > 5) were added to 5 lm pore size transwell inserts of 24 well plates (Corning Inc. Life Sciences, Lowell, MA, USA), in X-VIVO 20 media (Cambrex, Walkersville, MD, USA). Migration was assessed in duplicate in the presence or absence of 500 ng ⁄ ml CCL22 (R&D Systems). After 2-h incubation at 37°C and 5% CO 2 , samples were individually analyzed for expression of CD3, CD4, CD25 and CD127 expression by FACS to identify the Treg subpopulation among migrated cells. Relative chemoattraction by CCL22 among both donor groups was expressed as % Treg among CD4 + cells migrating in presence of CCL22 ⁄ % Treg migrating in absence of CCL22.
Evaluation and statistics
Immunostained slides were evaluated for infiltration of Treg by two independent investigators. The number of FoxP3 ⁄ CD3 double stained cells per section were counted as a percentage of the total number of CD3 stained cells per section. Mean % of Treg (CD3 + ⁄ FoxP3 + ) among T cells (CD3 + ) were compared among nonlesional, perilesional and lesional vitiligo patients versus adult as well as neonatal control skin and lentigo maligna samples, 4-8 samples each as indicated in legends. Data were analyzed by Student's T test using Excel software. In functional assays, the % suppression measured as described above (1 ) proliferation of combined helper T cells and regulatory T cells, divided by proliferation of separate helper T cells plus regulatory T cells) was compared among vitiligo patients (n = 3) and controls (n = 3) performing Student's T test. The percentage of Treg among T cells in PBMC samples analyzed by FACS was determined in five vitiligo and five control PBMC samples. Levels of expression for skin homing receptors and numbers of migrating Treg were FACS analyzed in terms of percentage of T lymphocytes and the mean and median fluorescence intensity as well as the %. The significance of a difference in Treg percentages was determined in a T test. Finally, the number of chemokine expressing cells per dermal area was estimated by immunohistochemistry and image analysis. Student's T tests was used to evaluate reduced expression of chemokines their receptors.
